Efficacy and safety of simvastatin 80 mg/day in hypercholesterolemic patients. The Expanded Dose Simvastatin U.S. Study Group.
about
Debate: "How low should LDL cholesterol be lowered?" Viewpoint: "It doesn't need to be very low"Assessing compliance of cardiologists with the national cholesterol education program (NCEP) III guidelines in an ambulatory care settingThe effects of lacidipine on the steady/state plasma concentrations of simvastatin in healthy subjectsEvaluation of atorvastatin efficacy and toxicity on spermatozoa, accessory glands and gonadal hormones of healthy men: a pilot prospective clinical trialPhysiogenomic analysis of statin-treated patients: domain-specific counter effects within the ACACB gene on low-density lipoprotein cholesterol?Rosuvastatin for the treatment of patients with hypercholesterolemia.Mechanisms and assessment of statin-related muscular adverse effects.Efficacy and safety of pitavastatin versus simvastatin: a meta-analysis of randomized controlled trials.The effects of rosuvastatin on lipid-lowering, inflammatory, antioxidant and fibrinolytics blood biomarkers are influenced by Val16Ala superoxide dismutase manganese-dependent gene polymorphism.Laboratory Medicine in the Clinical Decision Support for Treatment of Hypercholesterolemia: Pharmacogenetics of StatinsEffects of concomitant therapy with diltiazem on the lipid responses to simvastatin in Chinese subjects.Using primary care prescribing databases to determine drug switching and continuation of care.Lack of Potential Pharmacokinetic and Pharmacodynamic Interactions Between Piragliatin, a Glucokinase Activator, and Simvastatin in Patients With Type 2 Diabetes Mellitus.
P2860
Q24793416-51864BDC-886C-436F-AF5C-62BD785A41F0Q24794337-44617DF3-B4A3-4ED2-9CAA-ECB41B02FD12Q28361017-EE4A367F-8836-413B-A540-59F6F4856539Q33965084-CD099E5A-3024-4EFF-8702-7AD067BD6666Q34066977-D37B1304-F192-4781-9EE6-A4A60208DC25Q34509418-CA5B02BE-44D1-4534-B136-34FF827681FEQ34570995-4D5596DF-A379-4B36-BDBD-346B9602A9E1Q38229263-9D2D7731-FA27-4096-B763-1C88EFF7BA83Q38735798-C6129388-DEDA-4D33-9D82-85D48118B6DEQ38924930-499FC06D-DF5A-44FD-8D80-819D016A0565Q43164707-94C94A6E-32EF-4F45-8630-2D166210B6FAQ44509977-BFA9AC8A-1A99-4B54-A11D-07C6791837E5Q54245859-8FDF67EA-6FEF-43F2-897C-7899F9434761
P2860
Efficacy and safety of simvastatin 80 mg/day in hypercholesterolemic patients. The Expanded Dose Simvastatin U.S. Study Group.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Efficacy and safety of simvast ...... Simvastatin U.S. Study Group.
@en
Efficacy and safety of simvast ...... Simvastatin U.S. Study Group.
@nl
type
label
Efficacy and safety of simvast ...... Simvastatin U.S. Study Group.
@en
Efficacy and safety of simvast ...... Simvastatin U.S. Study Group.
@nl
prefLabel
Efficacy and safety of simvast ...... Simvastatin U.S. Study Group.
@en
Efficacy and safety of simvast ...... Simvastatin U.S. Study Group.
@nl
P2093
P1476
Efficacy and safety of simvast ...... Simvastatin U.S. Study Group.
@en
P2093
Davidson MH
Dujovne CA
Mitchel YB
Stepanavage ME
P304
P356
10.1016/S0002-9149(98)00421-4
P407
P577
1998-08-01T00:00:00Z